483
Shionogi Pharma Co. Ltd.Shionogi Pharma Co. Ltd. – FDA 483, Aug 5, 2016
Record Details
An FDA inspection of Shionogi Pharma Chemicals Co., Ltd. in Tokushima, Japan, revealed significant deficiencies across quality control, computerized systems, quality assurance, and manufacturing processes. The observations indicate a lack of robust data integrity controls, inadequate quality management system implementation, and insufficient process validation and documentation practices. These issues collectively suggest a moderate to severe level of non-compliance with cGMP regulations.
View Company Profile
ID · 2d8d6826-370e-44cb-80ab-c00149046066
Other documents for Shionogi Pharma Co. Ltd.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.